Please assess the completion status of the following clinical trial:

Trial Title: Nicotine Lozenges and Assisted Self-help for Smokeless Tobacco Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years old or over~* Currently using smokeless tobacco products as primary tobacco product~* Use smokeless tobacco for the last 6 months~* Currently want to quit~* Able to read and write English; and~* Willing to share phone number, e-mail, and mailing address with the research project~* complete informed consent process~Exclusion Criteria:~* have used behavioral or pharmacologic tobacco treatment in last 30 days~* medical history of unstable angina, myocardial infarction within the past 6 months, cardiac dysrhythmia other than medication-controlled atrial fibrillation or PSVT or medically treated or untreated hypertension with BP ≥ 180 systolic OR ≥ 100 diastolic~* have phenylketonuria (PKU)~* have another member of their household already participating in this study~* currently pregnant or nursing~* score of ≥ 15 on the Patient Health Questionnaire (PHQ-8)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Lozenge Self Help: self help materials & lozenge NRT. (Type: ACTIVE_COMPARATOR): Self-help materials + Commit® nicotine lozenges (4 mg)
- Lozenge Assisted Self-help: lozenge NRT, phone counseling, & self help materials (Type: EXPERIMENTAL): Self-help materials + Commit® nicotine lozenges (4 mg) + Phone counseling
- Assisted Self-Help: self-help materials & phone counseling without lozenges (Type: EXPERIMENTAL): Self-help materials + Phone counseling

Based on this trial design, predict the completion outcome and termination type (if applicable).